MLI is a provider of Interprofessional Continuing Education and has achieved Joint Accreditation with Commendation, allowing us to deliver accredited education designed to impact the practice behavior of the healthcare team, thus, improving patient outcomes. MLI provides credit for physicians, nurses, pharmacists, PAs, psychologists, social workers, dietitians, and optometrists. MLIʹs mission is to develop relevant, timely and targeted continuing education initiatives that promote problem‐solving and critical thinking.
MannKind Corporation
MannKind focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with orphan lung and endocrine diseases. We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as IPF, PAH and NTM. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where they can exert an effect locally or enter the systemic circulation. | At MannKind, we are committed to developing and commercializing innovative therapeutic products and devices for people living with endocrine and orphan lung diseases. Our approach begins with our cutting-edge technology and is driven by solutions-based scientists and medical professionals who are dedicated to helping people experience the very best life has to offer. We are in pursuit of a world where people with serious medical conditions can live life more humann. | MannKind Corporation is a biopharmaceutical company dedicated to transforming chronic use disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.
Insmed
Insmed is a global biopharmaceutical company dedicated to the development of treatments for serious and rare diseases. We have more than 700 employees throughout the U.S., Europe, and Japan, and we continue to build our global infrastructure and organizational capabilities. Our five core values—collaboration, accountability, passion, respect, and integrity—set the tone for our culture and guide the actions we take each day. | Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. Insmed is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed’s most advanced programs are in pulmonary and inflammatory conditions. Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe, and Japan. Visit www.Insmed.com to learn more.
Hyfe
Hyfe is the global leader in providing continuous, passive cough monitoring as an endpoint for clinical trials and research. Hyfe’s CoughMonitor Suite is a smartwatch-based solution used in numerous regulatory-focused drug development trials, from proof of concept to Phase 3 studies, as an exploratory or primary endpoint across therapeutic areas including refractory chronic cough, bronchiectasis, COPD, and more. Hyfe’s CoughMonitor Suite is a validated, accurate, and fully privacy-preserving solution for continuous cough monitoring. Hyfe’s cough monitoring has been used in over 50 research trials and has resulted in over 20 peer-reviewed publications spanning more than 18 therapeutic indications. Hyfe is also developing an evidence-based digital therapeutic (DTx) solution for cough hypersensitivity, which recently reported over a 40% reduction in cough frequency over 4 weeks. Hyfe’s DTx is already licensed for development as a prescription DTx in Japan, and Hyfe is actively seeking partners to address cough hypersensitivity as a treatable trait of respiratory conditions (e.g., asthma, among others) in other global markets.
Endo-Therapeutics, Inc.
Endo-Therapeutics, based in Clearwater, FL, is a leading medical device manufacturer with over 30 years of experience specializing in the design and development of single-use endoscopic devices. As one of the top domestic producers of biopsy forceps and polypectomy snares in the US, we are proud to deliver millions of single-use devices worldwide. We’ve recently expanded into the pulmonology market—our pulmonology products include Single-use Flexible Bronchoscopes, BioCeps Biopsy Forceps, and the EndoTBrush Cytology Brush.
Electromed, Inc.
The SmartVest Airway Clearance System by Electromed, Inc. uses high frequency chest wall oscillation (HFCWO), a proven clinical therapy that helps people around the world breathe better, stay healthier, and lead active and fulfilling lives. Along with a commitment to excellence and compassionate service, Electromed is focused on the mission of making life’s important moments possible — one breath at a time.® For additional information, visit www.smartvest.com or call 800-462-1045.
COPD Foundation
The COPD Foundation, a 501(c)(3) nonprofit organization, has a mission to help millions of people live longer and healthier lives by advancing research, advocacy, and awareness to stop COPD, bronchiectasis, and NTM lung disease. We do this by expanding services, accelerating innovations for more effective and affordable treatments, and promoting awareness and education, with the overarching goal of preventing chronic lung disease, slowing its progression, and ultimately finding a cure.
Canadian Thoracic Society
The Canadian Thoracic Society (CTS) is Canada’s national inter-professional specialty society for respirology bringing together over 1,000 members representing specialists, physicians, researchers and healthcare professionals from a variety of disciplines working in respiratory health. For more information on CTS, please visit our website at www.cts-sct.ca